Fernando Ramalho

ORCID: 0000-0003-3134-0502
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Liver Disease and Transplantation
  • Liver Diseases and Immunity
  • Hepatitis Viruses Studies and Epidemiology
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Systemic Lupus Erythematosus Research
  • Alcohol Consumption and Health Effects
  • Pediatric Hepatobiliary Diseases and Treatments
  • Diabetes and associated disorders
  • Drug-Induced Hepatotoxicity and Protection
  • Amoebic Infections and Treatments
  • Adrenal and Paraganglionic Tumors
  • Gastric Cancer Management and Outcomes
  • Animal Virus Infections Studies
  • HIV/AIDS drug development and treatment
  • Pericarditis and Cardiac Tamponade
  • HIV, Drug Use, Sexual Risk
  • Drug Transport and Resistance Mechanisms
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Vaccine Coverage and Hesitancy
  • Organ Transplantation Techniques and Outcomes
  • Urticaria and Related Conditions

Hospital de Santa Maria
2002-2019

Centro Hospitalar Lisboa Norte
2012-2019

Clinics Hospital of Ribeirão Preto
2019

University of Lisbon
1979-2018

Kanazawa University
2015

Takano Hospital
1998

Azienda Ospedaliero Universitaria San Giovanni Battista
1988

Abstract Background and aims The role of portal vein thrombosis (PVT) in the natural history cirrhosis is controversial. There are few prospective studies validating risk factors for development PVT. We analysed incidence, associated with PVT its influence on decompensations orthotopic liver transplant (OLT)‐free survival. Methods In this observational study between January 2014 March 2019, 445 consecutive patients chronic disease were screened finally 241 included. Factors OLT‐free survival...

10.1111/liv.14121 article EN Liver International 2019-04-25

Spontaneous bacterial peritonitis (SBP) is a known complication of advanced cirrhosis and presents high mortality rate. A polymorphonuclear (PMN) cell count >250/μl in the ascitic fluid current gold standard for diagnosing SBP.We evaluated accuracy point-of-care test (POCT) calprotectin patients with SBP.Eighty-eight admitted decompensation liver were studied including 41 (46.6%) SBP. Ascitic was measured using quantitative POCT developed by Bühlmann® .Calprotectin levels correlated PMN...

10.1002/jcla.21994 article EN Journal of Clinical Laboratory Analysis 2016-05-17

Abstract: Introduction: Hepatocellular carcinoma is a leading cause of death from cancer worldwide. Survival patients depends on tumor extension and liver function, but yet there no consensual prognostic model. Aims: To evaluate the influence survival pretreatment parameters (clinico‐laboratorial, extension, Okuda Cancer Liver Italian program (CLIP) staging) treatment modalities. Methods: We retrospectively analyzed 207 patients, diagnosed between 1993 2003. The initial was: surgery – six...

10.1111/j.1478-3231.2006.001285.x article EN Liver International 2006-06-27

Abstract Background & Aims Chronic liver disease is a major worldwide cause of morbidity and mortality. Palliative care policies are not clearly established in chronic disease. The NECPAL CCOMS ‐ ICO © ( NEC esidades PAL iativas/Palliative Needs) tool to identify palliative needs, including section for Aim: aim this study was needs patients hospitalised tertiary referral Liver Unit. Methods Single‐centre prospective observational study. One hundred twenty with cirrhosis were included...

10.1111/liv.13865 article EN Liver International 2018-04-23

Clastogenic factors (CFs) are composed of lipid peroxidation products, cytokines and other oxidants with chromosome-damaging properties. They regularly observed after radiation exposure in chronic inflammatory diseases, where they supposed to be risk for carcinogenesis. It appeared interest investigate their presence the plasma patients hepatitis C.CFs detected by chromosomal breakage studies. were compared malondialdehyde (MDA), total thiols (t-SH), alanine aminotransferase (ALT), viral...

10.1159/000007814 article EN Digestion 2000-01-01

In this work the identification and diagnosis of various stages chronic liver disease is addressed. The classification results a support vector machine, decision tree k-nearest neighbor classifier are compared. Ultrasound image intensity textural features jointly used with clinical laboratorial data in staging process. classifiers training performed by using population 97 patients at six different leave-one-out cross-validation strategy. best obtained machine radial-basis kernel, 73.20%...

10.1109/isbi.2011.5872504 article EN 2011-03-01

There are a few reports in the literature concerning pemphigus induced by interferon given for hepatitis C. We present case of 28-year-old woman with post-transfusional chronic C who developed ulcers and vesicles on her tongue, cheeks, posterior oropharynx vocal cords 5 months after beginning treatment recombinant alpha-2a. The direct indirect immunofluorescence was diagnostic vulgaris. drug promptly withdrawn; patient medicated prednisolone azathioprine recovered only 3 later. Although...

10.1097/00042737-200107000-00017 article EN European Journal of Gastroenterology & Hepatology 2001-07-01

Pruritus is a major symptom of primary biliary cirrhosis, cholestatic autoimmune disease which affects mostly middle-age women. Often, it can be severe and refractory to multiple treatments, affecting the patient's health-related quality life. Intense pruritus itself an indication liver transplantation, in extreme cases leading suicide. Its physiopathology has not yet been fully elucidated, but recent studies added elevation autotaxin lysophosphatidic acid group classic mechanisms already...

10.1136/bcr-2013-200634 article EN BMJ Case Reports 2013-11-14

The mechanisms of hepatocyte damage and the events that lead to high rates chronic liver disease in hepatitis C virus (HCV) infection remain unclear. Recent vitro studies have suggested HCV core protein may disrupt specific signalling pathways apoptosis. This prompted us study patients with to: determine extent apoptosis liver; evaluate whether clinical biochemical data are correlated histological findings; investigate if is related activity disease. Twelve were included study. Liver...

10.1046/j.1365-2893.2000.00219.x article EN Journal of Viral Hepatitis 2000-05-01

Chronic Liver Disease is a progressive, most of the time asymptomatic, and potentially fatal disease. In this paper, semi-automatic procedure to stage disease proposed based on ultrasound liver images, clinical laboratorial data. core algorithm two classifiers are used: k nearest neighbor Support Vector Machine, with different kernels. The were trained multi-modal feature set results obtained compared set. showed that using features, in association improve classification accuracy. support...

10.1109/iembs.2011.6091271 article EN Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2011-08-01

The antiviral treatment of Hepatitis C virus (HCV) infection is changing rapidly. Peginterferon and ribavirin are no longer the standard care therapy being replaced by new drugs with greater efficacy fewer adverse effects. These direct-acting antivirals (DAAs), incorporated in interferon-based or all-oral regimens, cure more than 90% infections, even patients before considered difficult to treat, such as cirrhotic non-responders. agents allow shortening duration, improving sustained response...

10.1016/j.jpge.2014.09.001 article PT cc-by-nc-nd GE Portuguese Journal of Gastroenterology 2014-11-01

Objective: To evaluate the prevalence of anti-hepatitis A virus (HAV) in an urban population, order to assess changing epidemiological pattern hepatitis A. Subjects: We studied 325 health care workers from Santa Maria Hospital and 201 students Medical School Lisbon. Results: The anti-HAV was lower younger age groups: 29% first 3 years Faculty compared 46% last years, P<0.001. overall for 35%, whereas less than 30 it 65%, These findings show a declining anti-HAV, particularly groups, when...

10.1097/00042737-199708000-00011 article EN European Journal of Gastroenterology & Hepatology 1997-08-01

We determined the prevalence of hepatitis B markers and compliance to vaccination in a University Hospital Santa Maria, Lisbon. The program was begun 1989 for all hospital personnel students medical school. screening included 2,360 health care workers 1,153 students; 57% (2,360/4,103) 41% (1,153/2,779) appeared vaccination. 16.8% (397/2,360) 5.5% (64/1,153) students, chronic carrier appearing 0.95% (22/2,360) 0.3% (4/1,153) students. departments with highest were Biochemical Laboratory (64%,...

10.1097/00004836-199906000-00007 article EN Journal of Clinical Gastroenterology 1999-06-01

We report the case of a 68-year-old African woman who presented with jaundice, hepatomegaly and anasarca. Clinical investigation disclosed severe intrahepatic cholestasis, nephrotic syndrome, erythrocytosis hypoglycemia. Diagnosis systemic AL amyloidosis was established by percutaneous liver biopsy. Bone marrow biopsy showed 32% myeloma cells. The patient started treatment melphalan prednisolone, but function deteriorated she died in hepatic failure complicated septic shock three weeks after...

10.1080/00365520701679298 article EN Scandinavian Journal of Gastroenterology 2008-01-01
Coming Soon ...